ATNM
Actinium Pharmaceuticals Inc
1.10$
+0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9,246.9% | – | – | – | -710.0% | – | – | -7,027.8% | – | – | -14.8% | -64.6% | |
| – | 245.7% | – | – | – | 25.2% | – | – | 228.9% | – | – | 0.7% | 2.5% | |
| – | 1,144.4% | – | – | – | 148.5% | – | – | 121.1% | – | – | 0.3% | 0.7% | |
| – | 874.1% | – | – | – | -62.5% | – | – | -1,676.7% | – | – | -99.0% | -103.5% | |
| – | 0.0% | – | – | – | 0.0% | – | – | 0.0% | – | – | 1.4% | 1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | -1.4% | – | |
| – | – | – | – | – | – | – | – | -230.0% | – | – | – | – | |
| – | – | – | – | – | -0.2% | – | – | -2.2% | – | – | 0.0% | 0.0% | |
| – | 1,471.6% | – | – | – | -0.4% | – | – | -232.2% | – | – | 0.0% | -0.6% | |
| – | -7,779.0% | – | – | – | -710.4% | – | – | -7,263.3% | – | – | -16.2% | -66.8% | |
| – | -9,246.9% | – | – | – | -710.0% | – | – | -7,027.8% | – | – | -16.2% | -66.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.